Medical Properties Trust (MPT) just absorbed a sharp downgrade to Underperform from RBC Capital Markets after its Q3 2026 report, with analysts highlighting tenant strain, liquidity pressure, and concern over a reduced earnings run rate.
The downgrade arrived after a steep reset in expectations. Medical Properties Trust's share price is down 30.5% over the past month and 52.0% year to date, contributing to a 5 year total shareholder return decline of 82.0%. This points to fading momentum as investors reprice liquidity and tenant risk.
Scan beyond Medical Properties Trust and stress test your watchlist against other REITs and income ideas with our handpicked 30 resilient stocks with low risk scores that have shown more resilient risk profiles so far this year.
After a slide to US$2.44 and a harsh downgrade, Medical Properties Trust now trades on far cheaper expectations. Do those compressed terms finally compensate you for the liquidity and tenant risk on the table?
Most Popular Narrative: 52% Undervalued
At a last close of $2.44 against a narrative fair value of about $5.11, Medical Properties Trust is framed as heavily discounted, with that gap resting on a specific story about refinancing, rent recovery, and hospital risk that investors need to test for themselves.
Successful refinancing of large European JVs at attractive fixed rates (for example, 5.1% over 10 years) and the ability to attract strong institutional investor interest underscores ongoing access to affordable capital, which should support net margin resilience and open pathways for asset recycling and growth investments.
See why 113 investors see Medical Properties Trust as 52% undervalued .
Result: Fair Value of $5.11 (UNDERVALUED)
Still, that discount only pays off if tenant concentration issues and the recent loss of US$31.6 million do not develop into deeper, prolonged cash flow strain.
Find out about the key risks to this Medical Properties Trust narrative .
Next Steps
Mixed signals around Medical Properties Trust can feel messy, so pull up the numbers directly, pressure test the story against your own assumptions, then weigh the 2 key rewards and 3 important warning signs .
Ready for more ideas beyond Medical Properties Trust?
Do not leave your research anchored to one troubled REIT. Broaden your opportunity set and pressure test fresh ideas using targeted stock lists built around different strengths.
-
Target potential mispricings by scanning companies that combine strong fundamentals with appealing valuations through our 18 high quality undiscovered gems .
-
Strengthen the quality of your portfolio by focusing on businesses with cleaner finances using the curated list of solid balance sheet and fundamentals (23 results) .
-
Lock in income potential you can actually quantify by reviewing companies offering robust yields through our focused 7 dividend fortresses .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MPT .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
